Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

13.55
+0.08000.59%
Post-market: 13.550.00000.00%16:34 EDT
Volume:1.22M
Turnover:16.52M
Market Cap:1.50B
PE:-8.85
High:13.84
Open:13.44
Low:13.32
Close:13.47
52wk High:17.49
52wk Low:3.11
Shares:110.54M
Float Shares:65.45M
Volume Ratio:0.95
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5305
EPS(LYR):-1.5305
ROE:-61.59%
ROA:-36.41%
PB:4.91
PE(LYR):-8.85

Loading ...

Amylyx Pharmaceuticals Inc - Cash Runway Expected to Fund Operations Through Potential Avexitide Commercialization and Into 2028

THOMSON REUTERS
·
Mar 03

Amylyx Pharmaceuticals Q4 Operating Income USD -36.605 Million VS. Ibes Estimate USD -40.4 Million

THOMSON REUTERS
·
Mar 03

Amylyx Pharmaceuticals Q4 Operating Expenses USD 36.605 Million

THOMSON REUTERS
·
Mar 03

Amylyx Pharmaceuticals Inc - Phase 3 Lucidity Trial Topline Data Anticipated in Q3 2026 & Commercial Launch in 2027

THOMSON REUTERS
·
Mar 03

Press Release: Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Mar 03

This Amylyx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

Benzinga_recent_news
·
Mar 03

Amylyx Pharmaceuticals Inc : Stifel Initiates Coverage With Buy Rating; Target Price $21

THOMSON REUTERS
·
Mar 03

Amylyx initiated with a Buy at Stifel

TIPRANKS
·
Mar 03

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 02

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 27

Amylyx Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference and Leerink Global Healthcare Conference

Reuters
·
Feb 26

Amylyx Pharmaceuticals Inc. published an update to their financial calendar

Reuters
·
Feb 24

Amylyx Pharmaceuticals Is Maintained at Buy by B of A Securities

Dow Jones
·
Feb 20

Amylyx price target raised to $19 from $15 at BofA

TIPRANKS
·
Feb 20

Amylyx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 10

Amylyx Co-CEO Justin B. Klee Reports Sale of Common Shares

Reuters
·
Feb 05

Amylyx Co-CEO Joshua B. Cohen Reports Disposal of Common Shares

Reuters
·
Jan 21

Amylyx Pharmaceuticals (AMLX) Valuation Check After AMX0318 Rare Disease Pipeline Update

Simply Wall St.
·
Jan 12

Amylyx Co-CEO Justin Klee Reports Sale of Common Shares

Reuters
·
Jan 09

Amylyx Pharmaceuticals Nominates AMX0318 as Candidate to Treat Post-Bariatric Hypoglycemia

MT Newswires Live
·
Jan 08